ReviewInternational journal of oncology2023

Dual inhibition of EGFR‑VEGF: An effective approach to the treatment of advanced non‑small cell lung cancer with EGFR mutation (Review).

Qian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.